The Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria and Treatment With Eculizumab

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3334
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited